Literature DB >> 9437822

Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma.

Y Momoi1, Y Okai, T Watari, R Goitsuka, H Tsujimoto, A Hasegawa.   

Abstract

A canine lymphoma cell line (CL-1) was established in culture from tumor cells found in the pleural fluid of a 7-year old female Japanese terrier with thymic form lymphoma. The CL-1 cells were positive for CD45 and MHC class II and negative for CD4, CD5, CD8, Thy-1 and B-cell specific antigen and surface immunoglobulin. The CL-1 cells had a rearranged T-cell receptor beta-chain gene and a germ-line form immunoglobulin gene, indicating that the CL-1 cells represented a monoclonally expanded population of canine alpha beta T-cell lineage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9437822     DOI: 10.1016/s0165-2427(97)00053-6

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  15 in total

1.  Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines.

Authors:  Jing Zhao; Rongfang Li; Aleksandra Pawlak; Marta Henklewska; Angelika Sysak; Lixin Wen; Jin-E Yi; Bożena Obmińska-Mrukowicz
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

2.  Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells.

Authors:  Satoshi Kambayashi; Kouji Minami; Yuka Ogawa; Takehiro Hamaji; Chung Chew Hwang; Masaya Igase; Hiroko Hiraoka; Takako Shimokawa Miyama; Shunsuke Noguchi; Kenji Baba; Takuya Mizuno; Masaru Okuda
Journal:  Can J Vet Res       Date:  2015-07       Impact factor: 1.310

Review 3.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

4.  Apoptosis in feline panleukopenia virus-infected lymphocytes.

Authors:  Y Ikeda; J Shinozuka; T Miyazawa; K Kurosawa; Y Izumiya; Y Nishimura; K Nakamura; J Cai; K Fujita; K Doi; T Mikami
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 5.  Beyond tradition and convention: benefits of non-traditional model organisms in cancer research.

Authors:  Rebecca M Harman; Sanjna P Das; Arianna P Bartlett; Gat Rauner; Leanne R Donahue; Gerlinde R Van de Walle
Journal:  Cancer Metastasis Rev       Date:  2020-10-28       Impact factor: 9.264

6.  NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.

Authors:  Alexandra Hebar; Barbara C Rütgen; Edgar Selzer
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

7.  Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma.

Authors:  Satoshi Kambayashi; Masaya Igase; Kosuke Kobayashi; Ayana Kimura; Takako Shimokawa Miyama; Kenji Baba; Shunsuke Noguchi; Takuya Mizuno; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2015-06-06       Impact factor: 1.267

Review 8.  Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.

Authors:  Maurice Zandvliet; Erik Teske
Journal:  Vet Sci       Date:  2015-08-12

9.  Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs.

Authors:  Hiroki Yamazaki; Naoki Miura; Yu-Chang Lai; Masashi Takahashi; Yuko Goto-Koshino; Momoi Yasuyuki; Munekazu Nakaichi; Hajime Tsujimoto; Asuka Setoguchi; Yasuyuki Endo
Journal:  J Vet Med Sci       Date:  2017-06-06       Impact factor: 1.267

10.  Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.

Authors:  James W Wells; Christopher H Evans; Milcah C Scott; Barbara C Rütgen; Timothy D O'Brien; Jaime F Modiano; Goran Cvetkovic; Slobodan Tepic
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.